Christopher Lyons Biography and Net Worth

Director of Sintx Technologies


Mr. Lyons has served on our board of directors since April 2025. Since January 2024, Mr. Lyons has served as principal consultant with BiotechExec, a provider of executive management services for medical device, biotech, diagnostics and digital health companies. Additionally, since January 2018, Mr. Lyons has served as the chief executive officer for Southern Metrics Consulting where he advises emerging medtech companies on commercialization and successful exits. Mr. Lyons worked for Medtronic Spine and Biologics, from February 2005 to January 2018 in various roles, including Director Global Business Development, Director of International Biologic Marketing and Senior Product Manager – International Biologics. Prior to joining Medtronic, Mr. Lyons worked for Smith & Nephew for 16 years in various roles including Clinical Therapies Sales Representative, Group Manager Orthopedic Navigation and Group Product Manager. Mr. Lyons holds a BBA, Marketing & Sales from Fogelman College of Business & Economics, University of Memphis. Mr. Lyons was nominated to serve as a director because his extensive background and experience in the context of the medical device industry enable him to make significant contributions to the Board.

What is Christopher Michael Lyons' net worth?

The estimated net worth of Christopher Michael Lyons is at least $17.54 thousand as of March 2nd, 2026. Mr. Lyons owns 8,292 shares of Sintx Technologies stock worth more than $17,538 as of October 7th. This net worth approximation does not reflect any other assets that Mr. Lyons may own. Learn More about Christopher Michael Lyons' net worth.

How do I contact Christopher Michael Lyons?

The corporate mailing address for Mr. Lyons and other Sintx Technologies executives is 1885 West 2100 Street, Salt Lake City, UT, 84119. Sintx Technologies can also be reached via phone at (855) 839-3500 and via email at [email protected]. Learn More on Christopher Michael Lyons' contact information.

Has Christopher Michael Lyons been buying or selling shares of Sintx Technologies?

Christopher Michael Lyons has not been actively trading shares of Sintx Technologies in the last ninety days. Most recently, on Monday, March 2nd, Christopher Michael Lyons bought 7,534 shares of Sintx Technologies stock. The stock was acquired at an average cost of $2.90 per share, with a total value of $21,848.60. Following the completion of the transaction, the director now directly owns 8,292 shares of the company's stock, valued at $24,046.80. Learn More on Christopher Michael Lyons' trading history.

Are insiders buying or selling shares of Sintx Technologies?

During the last twelve months, Sintx Technologies insiders bought shares 8 times. They purchased a total of 101,292 shares worth more than $378,064.28. The most recent insider tranaction occured on March, 2nd when Director Christopher Michael Lyons bought 7,534 shares worth more than $21,848.60. Insiders at Sintx Technologies own 4.1% of the company. Learn More about insider trades at Sintx Technologies.

Information on this page was last updated on 3/2/2026.

Christopher Michael Lyons Insider Trading History at Sintx Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/2/2026Buy7,534$2.90$21,848.608,292View SEC Filing Icon  
2/25/2026Buy758$2.96$2,243.68758View SEC Filing Icon  
See Full Table

Christopher Michael Lyons Buying and Selling Activity at Sintx Technologies

This chart shows Christopher Michael Lyons's buying and selling at Sintx Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sintx Technologies Company Overview

Sintx Technologies logo
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Read More

Today's Range

Now: $2.16
Low: $2.05
High: $2.20

50 Day Range

MA: $1.73
Low: $1.49
High: $2.23

2 Week Range

Now: $2.16
Low: $1.40
High: $4.64

Volume

22,856 shs

Average Volume

65,802 shs

Market Capitalization

$9.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A